Fig. 3
From: Patient selection for CAR T or BiTE therapy in multiple myeloma: Which treatment for each patient?
Bispecific antibody types. A IgG-like, formed by a crystallizable effector region and two variables, antigen-binding regions. IgG—immunoglobulin G, Fc—crystallizable region, Fab—antigen-binding region, VL—variable light chain, VH—variable heavy chain, CH—constant heavy chain; B BiTEs structure. scFv—single-chain variable fragments, Ab1—antibody 1, Ab2—antibody 2